Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00944216 · ClinicalTrials.gov registry record · Phase 4
Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study
A Phase 4 study, sponsored by Wright State University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT00944216: Clinical Trial Phase 4 study, sponsored by Wright State University.
NCT00944216 is a Phase 4 study that was terminated before completion, run by Wright State University. The registered enrollment target is 1 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00944216, a Phase 4 study, was terminated before completion, sponsored by Wright State University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
Keratosis pilaris (KP) is a benign skin condition that often is very frustrating for the patients and treating physicians. The investigators are interested to see if the study product is effective in treating moderate to severe KP.
Interventions
- DRUG Salkera Emollient Foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2009-06 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
Why NCT00944216 stopped before completion
NCT00944216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Salkera Emollient Foam is the first listed.
NCT00944216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00944216 about?
NCT00944216 is a clinical study titled "Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study". Keratosis pilaris (KP) is a benign skin condition that often is very frustrating for the patients and treating physicians. The investigators are interested to see if the study product is effective in treating moderate to severe KP.
What is the current status of trial NCT00944216?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2009-06. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00944216?
The interventions under investigation include: Salkera Emollient Foam (DRUG).
Who is sponsoring clinical trial NCT00944216?
This trial is sponsored by Wright State University, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00944216's enrollment target sits among peer trials
1 2000th of 2000 the lowest of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia